HIE Rundown 2-11-2015
This week’s Rundown includes: HealthLogix platform achieved the highest standards of community-wide interoperability at the 2015 IHE. CORHIO grew in participants and data by 111% and 118% respectively in 2014.
Read MoreThis week’s Rundown includes: HealthLogix platform achieved the highest standards of community-wide interoperability at the 2015 IHE. CORHIO grew in participants and data by 111% and 118% respectively in 2014.
Read MoreYesterday Senate Finance Committee Chairman Orrin Hatch and Ranking Member Ron Wyden released statements on the new GAO report on ICD-10. The report shows confidence that CMS is prepared to implement ICD-10 by the Oct.1 deadline.
The Government Accountability Office (GAO) is now accepting nominations for four openings on the Health IT Policy Committee. ONC is also looking for nominations for the Health IT Standards Committee.
By Adria Tomaszewski – Four great ideas were named first place winners of the Verizon Powerful Answers Award, a year-long global challenge to discover and help bring to market technology-based solutions with the potential to change our world.
ZirMed announced it was once again ranked Best in KLAS®, recognized as the #1 claims and clearinghouse vendor in the healthcare market. In other news, Allina Health and Health Catalyst have signed a definitive agreement valued at over $100 million.
The ONC Annual Meeting concluded on day 2 as they continued discussing their theme, Interoperable Health IT for a Healthy Nation. If you didn’t attend the meeting, check out the webcast.
By Daniel J. Marino – Organizations that begin to incorporate strategies around the “value proposition” will be in the best position to meet industry demands for value-based reimbursement. This will require a dedicated strategic “call to action” across organizations and their provider community.
One of the ways that HITECH Answers is different from other media sites is the sense of community. The thought leaders in our community are…
By Owen Faris & Jeffrey Shuren – At the Center for Devices and Radiological Health (CDRH), clinical trials are the foundation for our decisions to approve the most important medical devices—products that have the potential to save or sustain life, but that also present the greatest risk to patients.